a phase ii study combining cisplatin , vindesine , and dacarbazine was performed on patients with disseminated malignant melanoma by the european organization for research and treatment of cancer ( eortc ) malignant melanoma cooperative group ( mmcg ) .
C0010927
dacarbazine
C0025202
european organization